If you manage diabetes, the menopause transition adds a variable that almost nobody warns you about: hormone fluctuation changes insulin sensitivity, so readings that were stable for years start moving without any change in what you eat or do. This is well recognized clinically and badly covered in patient information. Here is what changes, and what to do about it.

Where we stand: Menova is an independent publication. We sell no hormones and no medication, we are not your doctor, and this is general education, not medical advice. Never change insulin or diabetes medication doses on your own — the adjustments described here belong with your diabetes team.

Why control gets harder

Several things move at once:

  • Estrogen and progesterone affect insulin sensitivity in opposite directions. In perimenopause, when both fluctuate erratically, sensitivity can shift within a single cycle — which is why readings become unpredictable rather than uniformly higher or lower.
  • Fat redistributes toward the abdomen as estrogen falls, and visceral fat worsens insulin resistance independently; see insulin resistance in menopause.
  • Muscle mass declines unless defended, and muscle is where most glucose is disposed of.
  • Sleep breaks down. Short and fragmented sleep measurably impairs glucose tolerance, so a week of night sweats can move your numbers on its own; see perimenopause sleep problems.

For women with type 1 diabetes, the cycle-linked variability many already notice can become more erratic before it settles. For type 2, the general trend is toward higher insulin resistance.

The symptoms that overlap — and the one that is dangerous to confuse

This is the part with real consequences.

Hypoglycaemia and a hot flash can feel almost identical: sudden sweating, palpitations, shakiness, anxiety, a wave of heat. If you take insulin or a sulfonylurea, treating a low as "just a hot flash" is a genuine risk.

The rule: test, do not assume. If you feel a flash and you are on medication that can cause hypoglycaemia, check your glucose. A continuous glucose monitor makes this much easier and is worth raising with your team if you are having frequent episodes you cannot distinguish.

Other overlaps: fatigue, blurred vision, frequent urination, thirst, and recurrent thrush or urinary infections all appear on both lists — see recurrent UTIs after menopause.

Can I take HRT with diabetes?

Usually yes — diabetes is not by itself a barrier — and there is a reasonable case for it.

Points to raise:

  • Transdermal estrogen is generally preferred. It avoids first-pass liver metabolism, which matters for clot risk and for triglycerides, and diabetes already raises cardiovascular risk; see HRT and blood clot risk.
  • Hormone therapy may modestly improve insulin sensitivity, and trial evidence has associated it with a lower incidence of new-onset type 2 diabetes. It is not approved or prescribed as a diabetes treatment, and should not be presented as one.
  • Your cardiovascular risk profile matters more than usual, so blood pressure, lipids, and kidney function belong in the conversation.
  • Expect to monitor more closely when starting, stopping, or changing dose, because insulin requirements can shift.

Our fuller treatment is in is HRT safe and HRT types and forms.

Practical adjustments that help

  • Test more often during the transition, especially if your pattern has become unpredictable. More data is what makes safe dose adjustment possible
  • Ask about a continuous glucose monitor if you do not already use one — it is the single most useful tool for a period of shifting sensitivity
  • Resistance training twice a week. Muscle is the main site of glucose disposal, so this improves control directly rather than only through weight; see strength training in menopause
  • Walk after meals — ten to fifteen minutes measurably blunts the post-meal rise
  • Protein and fibre at every meal, which flatten the curve; see eating for menopause
  • Treat the night sweats. Fixing sleep is a glucose intervention, not just a comfort one
  • Reconsider alcohol, which affects both hypoglycaemia risk and sleep; see alcohol in midlife

What diabetes adds to the menopause checklist

Some menopausal issues hit harder with diabetes and deserve active management rather than patience:

  • Vaginal and urinary symptoms. Higher glucose plus the tissue changes of menopause makes thrush and urinary infections more likely, and both worsen without treatment; see GSM and urinary changes
  • Gum disease, which is more common in diabetes and also rises after menopause — and periodontal inflammation is associated with worse glycaemic control in both directions; see menopause, teeth and gums
  • Eye and foot checks, which should not slip during a period when everything is being attributed to hormones
  • Cardiovascular risk, which rises after menopause and is already elevated in diabetes — diabetes also erodes some of women's relative cardiovascular protection; see heart health in menopause
  • Frozen shoulder, which is more common both in diabetes and in midlife women — early physiotherapy changes the outcome; see menopause joint pain

If you have prediabetes rather than diabetes

The transition is a meaningful moment: insulin sensitivity worsens around menopause, so this is when prediabetes is most likely to progress — and also when the interventions have most to work with. Ask for an HbA1c if you have not had one; see insulin resistance in menopause and health screening in your 50s.

GLP-1 medications, briefly

If you take one for diabetes, the midlife additions still apply: rapid weight loss takes muscle with it, so resistance training and protein matter more, not less. Our guides to GLP-1s in perimenopause and semaglutide versus tirzepatide cover the rest.

What to say at your next appointment

Bring it to whoever manages your diabetes, not only to whoever manages your menopause:

"My glucose control has become unpredictable over the last few months, and my cycle has changed. I think perimenopause may be part of it. Could we look at whether my medication needs adjusting, and could I discuss hormone therapy — transdermal, given my cardiovascular risk?"

That framing gets both halves onto the table, which is the main thing that goes wrong here: the diabetes team treats numbers without asking about hormones, and the menopause consultation treats symptoms without asking about glucose.

Our free 30-day symptom tracker has a note column that works alongside glucose logs, and the free printable visit prep sheet gives you one page for both conversations. The free 2-minute self-check organizes the symptom side — no account, not a diagnosis, and your answers never leave your device.

This article is general education, not medical advice. Do not change insulin or diabetes medication doses without your diabetes team. Seek urgent care for severe hypoglycaemia, and treat any suspected low by testing rather than assuming.

Sources: American Diabetes Association, NIDDK — Diabetes, The Menopause Society, and ACOG.